Using Prazosin to Treat Posttraumatic Stress Disorder and Associations: A Systematic Review

OBJECTIVE: A central adrenergic hyperactivation is described in the neurobiology of posttraumatic stress disorder (PTSD) with probable variable symptomatic impact. Few studies have evaluated using the alpha-1 adrenergic antagonist prazosin for such symptoms; however, given the likely pathophysiology...

Descripción completa

Detalles Bibliográficos
Autores principales: Paiva, Henrique Soares, Filho, Idiberto José Zotarelli, Cais, Carlos Filinto da Silva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neuropsychiatric Association 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169333/
https://www.ncbi.nlm.nih.gov/pubmed/33979949
http://dx.doi.org/10.30773/pi.2020.0411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169333/
https://www.ncbi.nlm.nih.gov/pubmed/33979949
http://dx.doi.org/10.30773/pi.2020.0411

Ejemplares similares